(Q51966483)

19 April 2018

title

Diagnosis and treatment of psychiatric disorders in children with a schizophrenic parent. (English)

1 reference

19 April 2018

0 references

R G Ross

1

1 reference

19 April 2018

N Compagnon

series ordinal

2

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 May 2001

1 reference

19 April 2018

published in

Schizophrenia Research

1 reference

19 April 2018

volume

50

1 reference

19 April 2018

page(s)

121-129

1 reference

19 April 2018

issue

1-2

1 reference

19 April 2018

Mental disorders and service utilization among youths from homeless and low-income housed families

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Cognitive and behavioral precursors of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Impaired attention, genetics, and the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Social competence deficits in adolescents at risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Prevalence of mental disorders among children in Valencia, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Heritability of schizophrenia. A controlled family history investigation in Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Family history study of major psychiatric disorders and syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Review of the NIMH Israeli Kibbutz-City Study and the Jerusalem Infant Development Study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Offspring of schizophrenics. III. Hyperactivity and neurological soft signs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

A children's global assessment scale (CGAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Motor impairment and antisocial behavior in adolescent males at high risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Interaction between genetic vulnerability and family environment: the Finnish adoptive family study of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Psychiatric disorders in the relatives of probands with affective disorders. The Yale University--National Institute of Mental Health Collaborative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900043-8

7 January 2021

10.1016/S0920-9964(00)00043-8

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

11378320

1 reference

19 April 2018